Mads Krogsgaard Thomsen, CEO of Novo Nordisk Foundation, discusses European competitiveness.

(Reuters) - European shares were subdued on Tuesday, as rising financials and healthcare shares countered broader losses ...

FRANKFURT: European shares rose on Tuesday, buoyed by gains in the healthcare and luxury sectors, but the uptick ...

European markets were subdued on Tuesday, with the STOXX 600 up 0.1 percent as healthcare and financials gains offset losses ...

Eli Lilly (LLY 1.45%) began a roll in late 2020 that lasted almost four years. During that time, it became the world's ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

Indian equity markets ended positively, with the Nifty closing above 23,100 despite intraday volatility. The index rebounded ...

Health care, ride sharing, and the emerging world of YouTube entertainers are among industries leading investors have picked ...

European shares held steady with slight gains in financials and healthcare despite global uncertainties over U.S. President Donald Trump's proposed tariffs. The market's cautious optimism was ...

The Mexico-based hormone clinic, which has online capabilities is doing its part to meet increased global demand for ...

EUROPEAN shares rose on Tuesday, buoyed by gains in the healthcare and luxury sectors, but the uptick was tempered by ...